Meigabalin Adverse Reactions

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Warnings Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Storage MIMS Class ATC Classification Thai FDA Category Presentation/Packing

Full Prescribing Info

Adverse Reactions

The most common adverse reactions resulting in discontinuation from pregabalin treatment groups were dizziness and somnolence.
Selected adverse drug reactions that were treatment related in the pooled analysis of clinical trials are listed in the table as follows by System Organ Class (SOC). The frequency of these terms has been based on all-causality adverse drug reactions in the clinical trial data set (very common (≥1/10), common (≥1/100, <1/100) and rare (<1/1,000)).
The adverse reactions listed may also be associated with the underlying and/or concomitant medications. (See Table 2.)

Click on icon to see table/diagram/image

The following adverse drug reactions were reported during POST-MARKETING SURVEILLANCE: See Table 3.

Click on icon to see table/diagram/image

View ADR Reporting Link

Meigabalin Adverse Reactions

pregabalin

Manufacturer:

Meiji

Distributor:

Meiji